Change in curve changed the ratio of Cmax [Bioanalytics]

posted by Compliance – India, 2015-03-23 08:39 (3716 d 13:47 ago) – Posting: # 14588
Views: 13,727

Dear All,

I request to share your comment on below issue:

We had run one 4 Way crossover study with 1-800 ng/ml and we get the ratio of Cmax 102%. We have revised the range 0.250- 250 ng/ml. we repeated the same samples which are initially run with 1-800 ng/ml.

After completion of repeat study we got ratio of Cmax 87%.

Now my question is does it impacted due to change in method (i.e. linearity) & processing volume? does the observed change in Cmax ratio is logical and acceptable or any doubt on the method can be raised?

Please note that the difference between the concentration obtain during initial analysis and repeat analysis is around 10-12%.

Please advice and share your thought on this matter.

Regards,

Compliance

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
22 visitors (0 registered, 22 guests [including 7 identified bots]).
Forum time: 23:26 CEST (Europe/Vienna)

An expert is someone who knows some of the worst mistakes
that can be made in his subject,
and how to avoid them.    Werner Heisenberg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5